For breast cancer, tumor cells that have high aldehyde dehydrogenase (ALDH) activity detected by the Aldefluor assay [7] or the combined low expression of cell surface cluster of differentiation (CD)24 and high expression of CD44 (i.e. CD24−CD44+ cells) have been defined as CSCs [8]. This evidence concerns the gene LDHA and neoplasm.